ERIN KELLY: Open Payments
NPI 1255109518 · LAKEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$339 in 15 payments from 10 companies in 2025. Trend: 2023 $49 · 2024 $1,351 · 2025 $339
Food & beverage: $339
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 3 | $65 |
| ABBVIE INC. | 2 | $53 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| Baxter Healthcare | 1 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $20 |
| Braeburn Inc. | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: REXULTI, VRAYLAR, HETLIOZ, Fluid Systems - Drug Delivery Systems, INVEGA SUSTENNA, INGREZZA, ARISTADA, BRIXADI.
Industry payments across CO — which companies pay providers there.
